ABVC BioPharma Announces Fiscal Year 2022 Financial and Operational Results

Go back to ABVC BioPharma Announces Fiscal Year 2022 Financial and Operational Results
(NASDAQ: ABVC) Delayed: 0.90 -0.06 (6.25%)
Previous Close $0.96    52 Week High $25.00 
Open $0.95    52 Week Low $1.00 
Day High $0.95    P/E N/A 
Day Low $0.86    EPS $0.00 
Volume 116,869